Osteogenic Differentiation of Recombinant Adeno-Associated Virus 2-Transduced Murine Mesenchymal Stem Cells and Development of an Immunocompetent Mouse Model for Ex Vivo Osteoporosis Gene Therapy
Authors:
- 1 December 2004
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 15 (12) , 1197-1206
Abstract
Gene therapy for osteopenic conditions including osteoporosis is a potential alternative to pharmacotherapy for cost effectiveness, long-term viability, and the ability to enhance bone mass by anabolic approaches. Increased understanding of mesenchymal stem cell (MSC) lineage differentiation during osteogenesis, and of the molecular pathways involved in bone cell production, provides an opportunity for the advancement of gene therapy approaches for osteopenic conditions. The potential of MSCs in osteoblast differentiation and the relative ease of MSC isolation and culturing offer a promising resource for the development of ex vivo gene therapy for bone defects. In an effort to develop ex vivo gene therapy for osteoporosis, we used gene-modified MSCs in a preclinical mouse model to determine the efficiency of transduction of murine MSCs by recombinant adeno-associated virus 2 (AAV) vectors carrying reporter genes and determined their osteogenic potential after recombinant AAV-mediated expression of bone morphogenic protein 2, known to induce osteoblast differentiation. Although surgical ovariectomy is believed to induce progressive bone loss in mouse models, similar to an osteoporosis-like phenotype in humans, several factors, including hormonal alteration and dietary habits, significantly affect both the onset and progression of the disease. Thus, in the present study, we determined the influence of these factors and developed an immunocompetent mouse model of osteoporosis with degenerative bone loss as in the human pathology.Keywords
This publication has 48 references indexed in Scilit:
- Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectorsJournal of Virology, 2004
- Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectorsGene Therapy, 2003
- Stage specific inhibition of osteoblast lineage differentiation by FGF2 and nogginJournal of Cellular Biochemistry, 2003
- Ingestion of Water-Soluble Soybean Fiber Prevents Osteopenia and Hypercholesterolemia Induced by Ovariectomy in RatsJournal of Agricultural and Food Chemistry, 2003
- Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGFBiochemical and Biophysical Research Communications, 2001
- Adeno-Associated Virus Type 2-Mediated Transduction of Human Monocyte-Derived Dendritic Cells: Implications for Ex Vivo ImmunotherapyJournal of Virology, 2001
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometryJournal of Bone and Mineral Research, 1992
- The effect of protein malnourishment and caging on growth and behavior of laboratory miceDevelopmental Psychobiology, 1974